Quantification of HCV Core Antigen to monitor efficacy of combination therapy of Sofosbuvir and Daclatasvir in patients with HCV infection as an alternative to HCV- PCR
Ghada Kamal Mohamed Abdel-Halim;
Abstract
Infection with hepatitis C virus (HCV) can lead to acute or chronic hepatitis, liver fibrosis, cirrhosis, end-stage liver disease, and hepatocellular carcinoma (Perz et al., 2006).
Disease progression after HCV infection depends on factors including gender, coinfection with HIV, alcohol consumption, and duration of chronic infection (Hajarizadeh et al., 2013).
Disease progression after HCV infection depends on factors including gender, coinfection with HIV, alcohol consumption, and duration of chronic infection (Hajarizadeh et al., 2013).
Other data
| Title | Quantification of HCV Core Antigen to monitor efficacy of combination therapy of Sofosbuvir and Daclatasvir in patients with HCV infection as an alternative to HCV- PCR | Other Titles | تحديد المستضاد اللبي لفيروس سي لمقياس كفائه الجمع بين العلاج بواسطه السوفوسبوفير والداكلاتاسفير في المرضي الذين يعانون من الالتهاب الفيروسي الكبدي سي كبديل عن ( بي سي ار ) | Authors | Ghada Kamal Mohamed Abdel-Halim | Issue Date | 2019 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| CC6028.pdf | 600.95 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.